AQR Capital Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-7,965	Closed	-$855K	–	2323
2023 Q1	$855K	Sell	7,965 -1,800	-18%	-$193K	﹤0.01%	1605
2022 Q4	$1.07M	Buy	9,765 +1,416	+17%	+$156K	﹤0.01%	1540
2022 Q3	$493K	Buy	+8,349	New	+$493K	﹤0.01%	1789